In a very well reasoned decision, a UK court invalidated a pharmaceutical patent that merely combined two existing medicinal substances (along with a third solvent). Given that Indian patent law tracks UK case law quite closely (perhaps even more so than it does US law), this decision from Justice Birss will be of great interest to our readers. The main patent in issue claimed a “Non-aqueous pharmaceutical composition for dermal use to treat psoriasis comprising a vitamin, a corticosteroid and a...
↧